Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Hypha Labs (FUNI) EBITDA (2016 - 2025)

Hypha Labs (FUNI) has disclosed EBITDA for 15 consecutive years, with -$490955.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, EBITDA rose 13.69% year-over-year to -$490955.0, compared with a TTM value of -$3.0 million through Sep 2025, down 64.28%, and an annual FY2025 reading of -$3.0 million, down 64.28% over the prior year.
  • EBITDA was -$490955.0 for Q3 2025 at Hypha Labs, up from -$536027.0 in the prior quarter.
  • Across five years, EBITDA topped out at $2620.0 in Q1 2021 and bottomed at -$1.3 million in Q4 2024.
  • Average EBITDA over 5 years is -$357333.7, with a median of -$280720.0 recorded in 2021.
  • The sharpest move saw EBITDA skyrocketed 100.44% in 2021, then tumbled 11644.12% in 2022.
  • Year by year, EBITDA stood at -$217590.0 in 2021, then skyrocketed by 50.67% to -$107336.0 in 2022, then soared by 34.26% to -$70564.0 in 2023, then crashed by 1749.76% to -$1.3 million in 2024, then surged by 62.39% to -$490955.0 in 2025.
  • Business Quant data shows EBITDA for FUNI at -$490955.0 in Q3 2025, -$536027.0 in Q2 2025, and -$669162.0 in Q1 2025.